| REDWOOD CITY, Calif.–(BUSINESS WIRE)–Pathwork Diagnostics, Inc., a pioneer in creating genomics-based diagnostics in oncology utilizing their proprietary informatics platform, announced today that results from a study involving its Pathwork® Tissue of Origin Test will be presented this week at the … Continue reading |
|
The post Cancer diagnostic test that may extend survival is cost effective: J Natl Cancer Inst appeared first on Health, Medical, and Science Updates.